Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations

C Ke, KMV Narayan, JCN Chan, P Jha… - Nature Reviews …, 2022 - nature.com
Nearly half of all adults with type 2 diabetes mellitus (T2DM) live in India and China. These
populations have an underlying predisposition to deficient insulin secretion, which has a key …

[HTML][HTML] Diabetes mellitus—Progress and opportunities in the evolving epidemic

ED Abel, AL Gloyn, C Evans-Molina, JJ Joseph… - Cell, 2024 - cell.com
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads
to complications that reduce quality of life and increase mortality. Diabetes pathophysiology …

Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes

ATN Nair, A Wesolowska-Andersen, C Brorsson… - Nature Medicine, 2022 - nature.com
Abstract Type 2 diabetes (T2D) is a complex chronic disease characterized by considerable
phenotypic heterogeneity. In this study, we applied a reverse graph embedding method to …

Statistical power for cluster analysis

ES Dalmaijer, CL Nord, DE Astle - BMC bioinformatics, 2022 - Springer
Background Cluster algorithms are gaining in popularity in biomedical research due to their
compelling ability to identify discrete subgroups in data, and their increasing accessibility in …

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment

C Herder, M Roden - Diabetologia, 2022 - Springer
The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies
and some insufficiently defined clinical features, does not reflect differences in aetiological …

Precision subclassification of type 2 diabetes: a systematic review

S Misra, R Wagner, B Ozkan, M Schön… - Communications …, 2023 - nature.com
Background Heterogeneity in type 2 diabetes presentation and progression suggests that
precision medicine interventions could improve clinical outcomes. We undertook a …

[HTML][HTML] ADA/EASD precision medicine in diabetes initiative: an international perspective and future vision for precision medicine in diabetes

JJ Nolan, AR Kahkoska, Z Semnani-Azad… - Diabetes …, 2022 - ncbi.nlm.nih.gov
The Precision Medicine in Diabetes Initiative (PMDI) was launched in 2018 by the American
Diabetes Association (ADA) in collaboration with the European Association for the Study of …

Phenotypic and genetic classification of diabetes

AJ Deutsch, E Ahlqvist, MS Udler - Diabetologia, 2022 - Springer
The historical subclassification of diabetes into predominantly types 1 and 2 is well
appreciated to inadequately capture the heterogeneity seen in patient presentations …

Artificial intelligence for diabetes care: current and future prospects

B Sheng, K Pushpanathan, Z Guan, QH Lim… - The Lancet Diabetes & …, 2024 - thelancet.com
Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise
care for people with diabetes and adapt treatments for complex presentations. However, the …

Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes

RD Leslie, RCW Ma, PW Franks, KJ Nadeau… - The Lancet Diabetes & …, 2023 - thelancet.com
Diabetes is a highly heterogeneous condition; yet, it is diagnosed by measuring a single
blood-borne metabolite, glucose, irrespective of aetiology. Although pragmatically helpful …